Xiaowen Mao
Impact in
- Biophysics top 2%
- Advanced Fluorescence Microscopy Techniques
- Cancer Research top 10%
- MicroRNA in disease regulation
- Cancer, Hypoxia, and Metabolism
- Cancer, Lipids, and Metabolism
Papers in
-
- MicroRNA in disease regulation 6
- Immunology 10
- Co-authors
- Colin J. R. SheppardJudy Wai Ping YamSze Keong TeyZhengyuan XiaIrene Oi‐Lin NgKyu-Won LeeFrankie Chi Fat KoZhi‐Dong Ge
- Journals
- Journal of Extracellular Vesicles (3 papers)Cancer Research (3 papers)Advanced Science (2 papers)Cancer Letters (2 papers)PLoS ONE (2 papers)
- Partner nations
- Hong KongChinaUnited States
In The Last Decade
Xiaowen Mao
26 papers receiving 880 citations
Peers
Comparison fields: 5 of 97
- Biophysics 127
- Cancer Research 251
- Immunology 188
- Molecular Biology 416
- Acoustics and Ultrasonics 5
Countries citing papers authored by Xiaowen Mao
This map shows the geographic impact of Xiaowen Mao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaowen Mao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaowen Mao more than expected).
Fields of papers citing papers by Xiaowen Mao
This network shows the impact of papers produced by Xiaowen Mao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaowen Mao. The network helps show where Xiaowen Mao may publish in the future.
Co-authors
The 25 scholars most cited alongside Xiaowen Mao, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 4 | |
| 3 | 2023 | 19 | |
| 4 | 2023 | 62 | |
| 5 | 2023 | 15 | |
| 6 | 2022 | 2 | |
| 7 | 2022 | 6 | |
| 8 | 2022 | 9 | |
| 9 | 2021 | 76 | |
| 10 | 2021 | 38 | |
| 11 | 2020 | 47 | |
| 12 | 2020 | 72 | |
| 13 | 2019 | 55 | |
| 14 | 2018 | 25 | |
| 15 | 2017 | 25 | |
| 16 | 2016 | 40 | |
| 17 | 2014 | 31 | |
| 18 | 2013 | 33 | |
| 19 | 2013 | 59 | |
| 20 | 2003 | 8 |
About Xiaowen Mao
Xiaowen Mao is a scholar working on Cancer Research, Immunology, Biophysics, Molecular Biology and Cell Biology, having authored 27 papers that have together received 892 indexed citations. Recurring topics across this work include Extracellular vesicles in disease (8 papers), MicroRNA in disease regulation (6 papers), Caveolin-1 and cellular processes (3 papers), Glycosylation and Glycoproteins Research (2 papers), Cancer Mechanisms and Therapy (2 papers), Optical Coherence Tomography Applications (2 papers), Drug Transport and Resistance Mechanisms (2 papers) and Digital Holography and Microscopy (2 papers). The work is most often cited by research in Biophysics (127 citations), Cancer Research (251 citations), Immunology (188 citations), Molecular Biology (416 citations) and Acoustics and Ultrasonics (5 citations). Xiaowen Mao has collaborated with scholars based in Hong Kong, China and United States. Frequent co-authors include Colin J. R. Sheppard, Judy Wai Ping Yam, Sze Keong Tey, Zhengyuan Xia, Irene Oi‐Lin Ng, Kyu-Won Lee, Frankie Chi Fat Ko, Zhi‐Dong Ge, Cherlie Lot Sum Yeung and Qingquan Lian. Their work appears in journals such as Journal of Extracellular Vesicles, Cancer Research, Advanced Science, Cancer Letters and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.